“…Agents that have been used as glucocorticoid-sparing agents include dapsone, minocycline, azathioprine, tacrolimus, mycophenolate mofetil, methotrexate, chlorambucil, and clofazimine. 7 Tumor necrosis factoralpha inhibitors, such as adalimumab or infliximab, have also been shown to be helpful in refractory disease, especially in patients with inflammatory bowel disease. Intralesional glucocorticoids and topical tacrolimus have also been used in treatment.…”